Luo Ying — SEC Form 4 filings

SEC reporting owner CIK 1959160. 3 Form 4 filings on record with FilingPulse; latest filed 2026-06-10.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-08-16 to 2026-06-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
GYRE THERAPEUTICS, INC. (GYRE)Chief Executive Officer, Director32 legs · 10,315 sh · $82,9272

Form 4 filings — Luo Ying

FiledFormIssuerReported transactionsSource
2026-06-104GYRE THERAPEUTICS, INC. (GYRE)Grant/award (A): 120,000 (derivative) @ $0EDGAR
2026-05-074GYRE THERAPEUTICS, INC. (GYRE)Sale (S): 179 @ $8.01 · Sale (S): 10,136 @ $8.04EDGAR
2024-08-164GYRE THERAPEUTICS, INC. (GYRE)Grant/award (A): 26,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1959160 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →